Lv6
2920 积分 2024-08-30 加入
Neue antimikrobielle Substanzen gegen zunehmende Resistenzen
3小时前
已完结
In vitro activity of cefiderocol and sulbactam–durlobactam against carbapenem-resistant Acinetobacter baumannii clinical isolates collected between 2019 and 2024
14天前
已完结
Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in China: A Nationwide Multicenter Study
14天前
已关闭
中国多黏菌素类抗菌药物临床合理应用多学科专家共识
17天前
已完结
Eravacycline: from clinical trials to its potential place in everyday therapy
20天前
已关闭
Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in China: A Nationwide Multicenter Study
21天前
已关闭
Eravacycline: from clinical trials to its potential place in everyday therapy
25天前
已关闭
Access to New Antibacterials in 10 Asian Countries: an Asian Network for Surveillance of Resistant Pathogens study
25天前
已完结
Access to New Antibacterials in 10 Asian Countries: an Asian Network for Surveillance of Resistant Pathogens study
1个月前
已关闭
Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis
1个月前
已完结
皖公网安备34019202002308
